Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Athira Pharma, Inc. (ATHA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 30,820,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Athira Pharma is a late clinical-stage biopharmaceutical company. Co.'s primary candidate, fosgonimeton (ATH-1017), is a blood brain barrier-penetrating, small molecule hepatocyte growth factor (HGF)/MET positive modulator. The primary target indication is Alzheimer's disease (AD). Co.'s product candidate for its neuropsychiatric program is ATH-1020, which is a small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and to distribute to the central nervous system. Co. has several preclinical candidates for non-AD indications, including ATH-1019, which is being developed to address peripheral indications such as peripheral neuropathy.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 605,686 685,698 2,157,060
Total Buy Value $0 $1,462,896 $1,705,913 $6,104,477
Total People Bought 0 1 2 6
Total Buy Transactions 0 3 6 13
Total Shares Sold 0 13,264 13,264 36,879
Total Sell Value $0 $38,598 $38,598 $102,919
Total People Sold 0 5 5 6
Total Sell Transactions 0 5 5 12
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 53
  Page 3 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Moebius Hans Chief Medical Officer   •       –      –    2021-05-18 4 A $14.45 $29,695 D/D 2,055 2,055     -
   Church Kevin Vice President of Discovery   •       –      –    2021-05-18 4/A A $14.45 $2,673 D/D 185 41,166     -
   Mileson Glenna Chief Financial Officer   •       –      –    2021-05-18 4 A $14.45 $22,455 D/D 1,554 83,519     -

  53 Records found
  1  2  3    
  Page 3 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed